tiprankstipranks
Vallon Pharmaceuticals (VLON)
NASDAQ:VLON
US Market

Vallon Pharmaceuticals (VLON) Financial Statements

0 Followers

Vallon Pharmaceuticals Financial Overview

Vallon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Vallon Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -1.39M$ -1.40M$ -1.77M$ -2.63M$ -3.09M
EBITDA$ -1.39M$ -1.24M$ -1.75M$ -2.62M$ -3.08M
Net Income Common Stockholders$ -1.58M$ -1.03M$ -1.77M$ -2.63M$ -3.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.78M$ 5.15M$ 6.97M$ 5.18M$ 7.51M
Total Assets$ 4.15M$ 5.57M$ 8.01M$ 5.94M$ 8.34M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 169.00K
Net Debt$ -3.78M$ -5.15M$ -6.97M$ -5.18M$ -7.34M
Total Liabilities$ 1.81M$ 2.11M$ 4.34M$ 2.58M$ 2.52M
Stockholders Equity$ 2.34M$ 3.46M$ 3.67M$ 3.36M$ 5.82M
Cash Flow-
Free Cash Flow$ -1.37M$ -1.85M$ -1.62M$ -2.29M$ -1.58M
Operating Cash Flow$ -1.37M$ -1.85M$ -1.62M$ -2.29M$ -1.58M
Investing Cash Flow$ 420.00K$ 1.33M$ 876.00K$ 1.15M$ -576.00K
Financing Cash Flow$ 0.00$ 31.00K$ 3.42M$ -23.00K$ -23.00K
Currency in USD

Vallon Pharmaceuticals Earnings and Revenue History

Vallon Pharmaceuticals Debt to Assets

Vallon Pharmaceuticals Cash Flow

Vallon Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis